Search Results
You are looking at 1-8 of 8
![<bold>Figure 1. </bold>](/view/journals/anpr/64/4/inline-i0003-3006-64-4-253-f01.png)
Antidepressant medications within the 4 therapeutic drug classes.
![<bold>Figure 2. </bold>](/view/journals/anpr/64/4/inline-i0003-3006-64-4-253-f02.png)
Vasoconstrictor interaction with tricyclic antidepressants and serotonin-norepinephrine reuptake inhibitors.
![<bold>Figure 3. </bold>](/view/journals/anpr/64/4/inline-i0003-3006-64-4-253-f03.png)
(A) Naïve nerve terminal. (B) Nerve terminal plus a monoamine oxidase inhibitor. (C) Nerve terminal with epinephrine. (D) Nerve terminal with ephedrine.
![<bold>Figure 4. </bold>](/view/journals/anpr/64/4/inline-i0003-3006-64-4-253-f04.png)
Lack of vasoconstrictor interaction with selective serotonin reuptake inhibitors.